Report Iraq - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Iraq - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Iraq: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Iraq

The Iraqi market for other medicaments for therapeutic or prophylactic uses was finally on the rise to reach $X in 2022, after two years of decline. Over the period under review, consumption, however, recorded a abrupt slump. Over the period under review, the market attained the peak level at $X in 2013; however, from 2014 to 2022, consumption remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Iraq

In 2016, overseas shipments of other medicaments for therapeutic or prophylactic uses decreased by X% to X kg for the first time since 2012, thus ending a three-year declining trend. In general, exports continue to indicate a significant expansion. The smallest decline of X% was in 2013. The exports peaked in 2016 and are likely to continue growth in years to come.

In value terms, exports of other medicaments for therapeutic or prophylactic uses totaled $X in 2016. Over the period under review, exports posted significant growth. The smallest decline of X% was in 2013. The exports peaked in 2016 and are expected to retain growth in the immediate term.

Exports by Country

Turkey (X kg) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Iraq, accounting for a approx. X% share of total exports.

From 2012 to 2016, the average annual rate of growth in terms of volume to Turkey was relatively modest.

From 2012 to 2016, the average annual rate of growth in terms of value to Turkey was relatively modest.

Export Prices by Country

In 2016, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, remaining constant against the previous year. Overall, the export price posted a significant increase. The pace of growth was the most pronounced in 2013 an increase of X%. The export price peaked in 2016 and is likely to continue growth in the immediate term.

As there is only one major export destination, the average price level is determined by prices for Turkey.

From 2012 to 2016, the rate of growth in terms of prices for Jordan amounted to X% per year.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Iraq

In 2022, purchases abroad of other medicaments for therapeutic or prophylactic uses was finally on the rise to reach X tons after two years of decline. Overall, imports, however, continue to indicate a abrupt shrinkage. Imports peaked at X tons in 2013; however, from 2014 to 2022, imports stood at a somewhat lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. In general, imports, however, recorded a abrupt decrease. Imports peaked at $X in 2014; however, from 2015 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Jordan (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Iraq, accounting for a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Jordan exceeded the figures recorded by the second-largest supplier, Egypt (X tons), fourfold. Iran (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Jordan stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Egypt (X% per year) and Iran (X% per year).

In value terms, Jordan ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Iraq, comprising X% of total imports. The second position in the ranking was taken by the United Arab Emirates ($X), with a X% share of total imports. It was followed by Iran, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Jordan stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United Arab Emirates (X% per year) and Iran (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, picking up by X% against the previous year. In general, the import price saw resilient growth. The most prominent rate of growth was recorded in 2019 when the average import price increased by X%. Over the period under review, average import prices reached the peak figure in 2022 and is likely to continue growth in years to come.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Spain ($X per ton), while the price for Switzerland ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Spain (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

China constituted the country with the largest volume of consumption of other medicaments for therapeutic or prophylactic uses, accounting for 34% of total volume. Moreover, consumption of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest consumer, India, threefold. The United States ranked third in terms of total consumption with an 8.1% share.
The country with the largest volume of production of other medicaments for therapeutic or prophylactic uses was China, accounting for 37% of total volume. Moreover, production of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest producer, India, threefold. The third position in this ranking was occupied by the United States, with a 9.9% share.
In value terms, Jordan constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Iraq, comprising 83% of total imports. The second position in the ranking was occupied by the United Arab Emirates, with a 4.5% share of total imports. It was followed by Kuwait, with a 4.5% share.
In 2016, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $83,897 per ton, remaining relatively unchanged against the previous year.
In 2020, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $27,844 per ton, dropping by -6.9% against the previous year.

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Iraq. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS

Country coverage:

  • Iraq

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Iraq
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - Iraq